Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro
Wang, Z.; Lorenzi, J. C. C.; Muecksch, F.; Finkin, S.; Viant, C.; Gaebler, C.; Cipolla, M.; Hoffman, H.-H.; Oliveira, T. Y.; Oren, D. A.; Ramos, V.; Nogueira, L.; Michailidis, E.; Robbiani, D. F.; Gazumyan, A.; Rice, C. M.; Hatziioannou, T.; Bieniasz, P. D.; Caskey, M.; Nussenzweig, M. C.
Show abstract
SARS-CoV-2 primarily infects cells at mucosal surfaces. Serum neutralizing antibody responses are variable and generally low in individuals that suffer mild forms of the illness. Although potent IgG antibodies can neutralize the virus, less is known about secretory antibodies such as IgA that might impact the initial viral spread and transmissibility from the mucosa. Here we characterize the IgA response to SARS-CoV-2 in a cohort of 149 individuals. IgA responses in plasma generally correlate with IgG responses and clones of IgM, IgG and IgA producing B cells that are derived from common progenitors are evident. Plasma IgA monomers are 2-fold less potent than IgG equivalents. However, IgA dimers, the primary form in the nasopharynx, are on average 15 times more potent than IgA monomers. Thus, secretory IgA responses may be particularly valuable for protection against SARS-CoV-2 and for vaccine efficacy.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection 97%
- The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD 97%
- Transient anti-interferon autoantibodies in the airways are associated with efficient recovery from COVID-19 96%
Similar papers in this journal
- Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages 98%
- Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles 96%
- Memory B cell Development in Response to mRNA SARS-CoV-2 and Nanoparticle Immunization in Mice 95%
Similar papers in this journal
- High-affinity, neutralizing antibodies to SARS-CoV-2 can be made in the absence of T follicular helper cells 96%
- CD4-binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wildtype animals 96%
- Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.